Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan.

The adherence will be evaluate using the 8-item Morisky Medication Adherence Scale (MMAS-8), in both arms. The MMAS-8 will provide an overall assessment of all treatments prescribed in the context of stroke.

This score is an 8-item self-administered questionnaire, validated in French, intended for adults, which allows patients to be classified into three groups according to their score:

• High adherence: score = 8
• Moderate adherence: score from 6 to <8
• Low adherence: score < 6 For the primary analysis, adherence will be considered as a binary outcome: high adherence versus moderate or low adherence.

Description of medication adherence by therapeutic class compared with prescriptions at hospital discharge, in both groups, based on patient self-report.

Evaluation of the proportion of patients attending the post-stroke follow-up consultation in both groups.

Evaluation of the proportion of rehabilitation interventions completed (physiotherapy and/or speech therapy), calculated relative to what was prescribed at hospital discharge (number of completed prescriptions per patient / number of prescribed rehabilitation interventions), in both groups, based on patient self-report.

Evaluation of the proportion of prescribed post-stroke complementary investigations completed, calculated relative to what was prescribed at hospital discharge (number of completed tests / number of prescribed tests), in both groups based on patient self-report.

Comparison of mean composite scores for overall adherence to the post-stroke care plan between the two groups : This composite score (range: 0-3), developed for this study, defines three adherence categories:

• High adherence: score ≥ 2
• Moderate adherence: score ≥ 1.5 to < 2
• Low adherence: score < 1.5

Comparison of mean scores on the "My Stroke Knowledge" questionnaire between the two groups.

This score assesses patient knowledge of essential stroke-related information. It was inspired by the Stroke Knowledge Score used in a study by Benoit C. conducted at Foch Hospital.

A 2-item self-administered questionnaire [Appendix 2] was developed to assess:

• Knowledge of main stroke warning signs (5 points)
• Appropriate response in case of symptom onset (2 points) These two components will be analyzed separately, and changes in mean scores will be compared between groups.

A score ≥5 (including the full 2 points for appropriate response) indicates very good stroke knowledge.

Proportion of patients with blood pressure within the target range:

• Either ≤135mmHg/85mmHg based on the average of home blood pressure self-measurements
• Or ≤140mmHg/90mmHg based on blood pressure measurements taken during consultations in both groups

Proportion of patients who achieved the target reduction of 1 mmol/L in LDL in both groups and description of the differences between the level measured at discharge and the levels measured during follow-up visits (in mmol/L), in both groups .

Proportion of patients diagnosed with diabetes via fasting blood glucose measurement in both groups Measure unit : g/l

Among diabetic patients: proportion of patients who achieved the personalised HbA1c target, in both groups Creatinine levels will be monitored as a simple follow-up, without a specific target to be achieved Measure unit : g/l

Proportion of patients who have completely stopped smoking (self-reported), in both groups

Mean difference in body mass index (BMI) between the two groups weight and height will be combined to report BMI in kg/m^2).

Comparison of mean Stroke-Specific Quality of Life (SS-QOL) scores between groups. This patient-reported outcome assesses health-related quality of life specific to stroke. Patients respond based on the previous week.

The total score (49-245) includes multiple domains (energy, family roles, language, mobility, mood, etc.). Each domain will be assessed at each visit and its evolution analyzed. Higher scores indicate better functioning .

Comparison of mean Hospital Anxiety and Depression Scale (HADS) scores between groups.

This validated instrument (French version available) screens for anxiety and depressive symptoms in post-stroke patients.

It includes 14 items (scored 0-3):

• 7 for anxiety
• 7 for depression Scores ≥8 indicate possible symptoms, and ≥11 indicate definite symptoms. Scores will be assessed at each visit and their evolution analyzed

Comparison of mean modified Rankin Scale (mRS) scores between groups. This scale (0-6) assesses disability and its impact on daily activities and return to normal life. Its evolution will be analyzed. A validated French structured interview version will be used

Comparison of mean National Institutes of Health Stroke Scale (NIHSS) scores between groups.

This scale (0-40) evaluates neurological deficit severity and is widely used in neurovascular practice. Lower scores indicate fewer neurological sequelae. Scores will be assessed at each visit and their evolution analyzed.